Showing results (491-500 of 559) with videos related to
Sort By:
Pageof 56
JAAD International|February 3, 2026
Prevalence, multiterritorial vascular distribution, and burden of subclinical atherosclerosis in psoriasis: The EDSAP studyCarlota Abbad-Jaime de Aragon, Emilio Berna-Rico, Alba Lecumberri, et al.AJNR. American Journal of Neuroradiology|November 6, 2020
Neurite Orientation Dispersion and Density Imaging for Assessing Acute Inflammation and Lesion Evolution in MSS Sacco, E Caverzasi, N Papinutto, et al.Annals of the Rheumatic Diseases|July 31, 2016
Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysisEli M Miloslavsky, Ray P Naden, Johannes W J Bijlsma, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|January 10, 2018
Harnessing electronic medical records to advance research on multiple sclerosisVincent Damotte, Antoine Lizée, Matthew Tremblay, et al.Frontiers in Neurology|February 9, 2023
Dual ankyrinG and subpial autoantibodies in a man with well-controlled HIV infection with steroid-responsive meningoencephalitis: A case reportChristopher M Bartley, Thomas T Ngo, Cathryn R Cadwell, et al.JAMA Neurology|November 28, 2022
Autoimmune Encephalitis Misdiagnosis in AdultsEoin P Flanagan, Michael D Geschwind, A Sebastian Lopez-Chiriboga, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 7, 2019
Association of aortic vascular uptake of 18FDG by PET/CT and aortic wall thickness by MRI in psoriasis: a prospective observational studyJacob W Groenendyk, Parag Shukla, Amit K Dey, et al.Circulation Research|September 23, 2016
GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in PsoriasisAditya A Joshi, Joseph B Lerman, Tsion M Aberra, et al.Brain Communications|July 25, 2026
The ILLUMINATE natural history study in colony-stimulating factor 1 receptor-related adult-onset leukoencephalopathy with axonal spheroids and pigmented gliaDavid S Lynch, Charles Wade, Ludger Schöls, et al.The Journal of Investigative Dermatology|February 24, 2020
A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)Joel M Gelfand, Daniel B Shin, Kristina Callis Duffin, et al.Pageof 56